Praxis CMO Bernard Ravina to step down, become part-time strategic advisor

Praxis Precision Medicines, Inc.

Bernard Ravina, Chief Medical Officer, transitions to part-time strategic advisor effective Aug 1, 2022.
Cash payment of $373,688 paid over consulting period ending May 1, 2023.
Outstanding equity awards will continue to vest during consulting period subject to service.
Health benefits continuation provided during consulting period; payment subject to signing release.
Ravina resigns from all officer and director positions with the Company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Bernard Ravina

Chief Medical Officer

PRAX · Praxis Precision Medicines, Inc.

Effective: 2022-08-01
Filed: July 26, 2022, 7:59 PM ET

On July 21, 2022, Bernard Ravina, Chief Medical Officer of Praxis Precision Medicines, Inc. (the “ Company ”), who is currently on leave attending to family medical matters, and the Company mutually decided that Dr. Ravina will transition from his full-time position as Chief Medical Officer to a part-time role as strategic advisor to the Company on August 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bernard Ravina changed role as Chief Medical Officer at Praxis Precision Medicines, Inc..

Action: transitioned
Role: Chief Medical Officer

Exact text from the filing

On July 21, 2022, Bernard Ravina, Chief Medical Officer of Praxis Precision Medicines, Inc. (the “ Company ”), who is currently on leave attending to family medical matters, and the Company mutually decided that Dr. Ravina will transition from his full-time position as Chief Medical Officer to a part-time role as strategic advisor to the Company on August 1, 2022.

View on SEC.gov

Praxis Precision Medicines, Inc. filing history →

Source: SEC EDGAR

accession 0001689548-22-000099

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.